new warnings about using rosiglitazone (Avandia) in patients with ANY degree of heart failure

You'll see new warnings about using rosiglitazone (Avandia) in patients with ANY degree of heart failure.

Physicians already avoid giving rosiglitazone or pioglitazone (Actos) to patients with severe heart failure.

Now there's evidence that rosiglitazone increases cardiac risk in patients with LESS severe heart failure.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote